Garcia Marino
- SEC CIK
- 0001669866
In the past year, 2 open-market sale filings worth $28.0M and no purchases.
Current role at each company
- AGMB AgomAb Therapeutics NVDirectoras of Sep 15, 2026
- DNTH Dianthus Therapeutics, Inc.CEO AND PRESIDENTas of Aug 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $28.0M
- 2 filings
- Net
- −$28.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Garcia Marino as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DNTH Dianthus Therapeutics, Inc.
CEO AND PRESIDENT2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 (view filing)6:30 PM ET | Aug 7 | Same day | Garcia MarinoCEO AND PRESIDENT | SSale | −166.0K | $108.11 | −$17.9M | −71.8%65.3K after | 7 lots10b5-1 |
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Garcia MarinoCEO AND PRESIDENT | SSale | −122.9K | $81.49 | −$10.0M | −100.0%0 after | 5 lots10b5-1 |